Achieving coronary plaque regression: a decades-long battle against coronary artery disease. (3rd April 2022)

• Record Type: Journal Article
• Authors: Manubolu, Venkat S.; Budoff, Matthew J.
• Is Part Of: Expert review of cardiovascular therapy. Volume 20:Number 4(2022)
• Page Start: 291
• Page End: 305
• Publication Date: 2022-04-03
• Subjects: Atherosclerosis -- CAD -- plaque regression -- IVUS -- CCTA -- OCT; Cardiovascular agents -- Research -- Periodicals; 616.12061
• DOI: 10.1080/14779072.2022.2069559
• Languages: English
• ISSNs: 1477-9072

Abstract

ABSTRACT: Introduction: Traditionally atherosclerosis was thought to be progressive and medical treatment solely focused on delaying the progression of atherosclerosis rather than treating the disease itself. Multiple recent studies, however, have demonstrated a significant decrease in cardiovascular mortality with the use of additional anti-atherosclerotic therapies beyond statins. Consistent with these observations, mechanistic studies indicate that these additional anti-atherosclerotic therapies have a positive effect on both halting and reversing the course of atherosclerosis. Areas Covered: We examine the progression of atherosclerosis and the efficacy of various anti-atherosclerotic treatment classes in this review utilizing multimodality imaging techniques. Searches were conducted in electronic databases: PubMed and EMBASE for all peer reviewed publications that examined coronary plaque progression, regression and stabilization using different imaging modalities and antiatherosclerosis therapies. All relevant published articles on this topic were identified and their reference lists were screened for relevance. Expert Opinion: Though lipoprotein levels have traditionally been the target for antiatherosclerosis medication, several newer strategies have emerged creating novel targets in the treatment of coronary atherosclerosis. Using a combination of antiatherosclerosis therapies in conjunction with noninvasive imaging modalities like CCTA to directly visualize the plaque, is currently the focus of the future, with the aim of preventing and reversing atherosclerosis.